Faye Zhang

Company: Pfizer

Job title: Associate Director

Seminars:

Utilizing PK Characterisation & Exposure-Response Analysis to Support Dosing in Paediatric Populations 2:00 pm

Population PK analysis indicated the pharmacokinetics of brentuximab vedotin (BV) were consistent in adult and pediatric patients BV ADC exposures were lower in patients aged 2 to <12 years vs. ≥12 years following body weight dosing Exposure-Response analyses and additional age/body weight subgroup analyses showed consistent benefit-risk profiles across age groups; these findings support the…Read more

day: Conference Day 1